Download to read offline
More Related Content
Similar to nanobiotechnology, achievements and development prospects
nanobiotechnology, achievements and development prospects
- 1.
- 2. 02 03 01 CONTENTS Concepts of nanobiotechnology Achievementsof nanobiotechnology Development prospects
- 3.
- 4. Nanobiotechnology is adiscipline in which tools from nanotechnology are developed and applied to study biological phenomena. For example, nanoparticles can serve as probes, sensors or vehicles for biomolecule delivery in cellular systems.
- 5. Nanobiotechnology is aninterdisciplinary field that encompasses the applications of nanomaterials in biotechnology. This field has significant applications in medicine, health, imaging, immunoproteomics, drug delivery, tissue engineering, cosmetics, agriculture, and pharmacy. Nanobiotechnology has been instrumental in developing intelligent drug delivery and gene therapy tools, nanobiosensors, nanodiagnostics, nanobioconstructs, nanofluidic devices, and bio-compatible nanodevices. Nanoparticles, nanomaterials, and nanocolloids can be synthesized by using biological, chemical, and physical methods. Currently, there is an impending need for the development of cost-effective and environment- friendly methods for the synthesis of biocompatible nanoparticles.
- 6. Achievements 02 Diagnostic applications Therapeutic applications
- 7. 1. Detection: Many currentlyused/conventional clinical tests reveal the presence of a molecule or a disease causing organism by detecting the binding of a specific antibody to the disease-related target. Traditionally, such tests are performed by conjugating the antibodies with inorganic/organic dyes and visualizing the signals within the samples through fluorescence microscopy or electronic microscopy. However, dyes often limit the specificity and practicality of the detection methods. Nanobiotechnology offers a solution by using semiconductor nanocrystals (also referred to as "quantum dots"). These minuscule probes can withstand significantly more cycles of excitations and light emissions than typical organic molecules, which more readily decompose. Diagnostic applications
- 8. 2. Individual targetprobes Despite the advantages of magnetic detections, optical and colorimetric detections will continue to be chosen by the medical community. Nanosphere (Northbrook, Illinois) is one of the companies that developed techniques that allow/allowing doctors to optically detect the genetic compositions of biological specimens. Nano gold particles studded with short segments of DNA form the basis of the easy-to-read test for the presence of any given genetic sequence. If the sequence of interest in the samples, it binds to complementary DNA tentacles on multiple nanospheres and forms a dense web of visible gold balls. This technology allows/facilitates the detection of pathogenic organisms and has shown promising results in the detection of anthrax, giving much higher sensitivity than tests that are currently being used. Diagnostic applications
- 9. 3. Protein chips Proteinsplay the central role in establishing the biological phenotype of organisms in healthy and diseased states and are more indicative of functionality. Hence, proteomics is important in disease diagnostics and pharmaceutics, where drugs can be developed to alter signaling pathways. Protein chips can be treated with chemical groups, or small modular protein components, that can specifically bind to proteins containing a certain structural or biochemical motif. Two companies currently operating in this application space are Agilent, Inc. and NanoInk, Inc. Agilent uses a non-contact ink-jet technology to produce microarrays by printing oligos and whole cDNAs onto glass slides at the nanoscale. NanoInk uses dip-pen nanolithography (DPN) technology to assemble structure on a nanoscale of measurement. Diagnostic applications
- 10. 4. Sparse celldetection Sparse cells are both rare and physiologically distinct from their surrounding cells in normal physiological conditions (e.g. cancer cells, lymphocytes, fetal cells and HIV-infected T cells). They are significant in the detection and diagnosis of various genetic defects. However, it is a challenge to identify and subsequently isolate these sparse cells. Nanobiotechnology presents new opportunities for advancement in this area. Scientists developed nanosystems capable of effectively sorting sparse cells from blood and other tissues. This technology takes advantage of/exploits the unique properties of sparse cells manifested in differences in deformation, surface charges and affinity for specific receptors and/or ligands. For example, by inserting electrodes into microchannels, cells can be precisely sorted based on surface charge. They can also be sorted by using biocompatible surfaces with precise nanopores. The nano-biotechnology center at Cornell University (NBTC) is currently using these technologies to develop powerful diagnostic tools for the isolation and diagnosis of various diseases. Diagnostic applications
- 11. 5. Nanotechnology asa tool in imaging Intracellular imaging can be made possible through labelling of target molecules with quantum dots (QDs) or synthetic chomophores, such as fluorescent proteins that will facilitate direct investigation of intracellular signalling complex by optical techniques, i. e. confocal fluorescence microscopy or correlation imaging. Diagnostic applications
- 12. 1. Drug Delivery: Nanoparticlesas therapeutics can be delivered to targeted sites, including locations that cannot be easily reached by standard drugs. For instance, if a therapeutic can be chemically attached to a nanoparticle, it can then be guided to the site of the disease or infection by radio or magnetic signals. These nanodrugs can also be designed to "release" only at times when specific molecules are present or when external triggers (such as infrared heat) are provided. At the same time, harmful side effects from potent medications can be avoided by reducing the effective dosage needed to treat the patient. By encapsulating drugs in nanosized materials (such as organic dendrimers, hollow polymer capsules, and nanoshells), release can be controlled much more precisely than ever before. Drugs are designed to carry a therapeutic payload (radiation, chemotherapy or gene therapy) as well as for imaging applications. Many agents, which cannot be administered orally due to their poor bioavailability, will now have scope of use in therapy with the help of nanotechnology. Nano-formulations offer protection for agents vulnerable to degradation or denaturation when exposed to extreme pH, and also prolong half-life of a drug by expanding retention of the formulation through bioadhesion. Another broad application of nanotechnology is the delivery of antigens for vaccination. Recent advances in encapsulation and development of suitable animal models have demonstrated that microparticles and nanoparticles are capable of enhancing immunization Therapeutic applications
- 13. 2. Gene delivery Currentgene therapy systems suffer from the inherent difficulties of effective pharmaceutical processing and development, and the chance of reversion of an engineered mutant to the wild type. Potential immunogenicity of viral vectors involved in gene delivery is also problematic. To address this issue, nanotechnological tools in human gene therapy have been tested and nanoparticle-based nonviral vectors (usully 50-500 nm in size) in transportation of plasmid DNA described. Therefore, successful introduction of less immunogenic nanosize gene carriers as a substitution of the disputed viral vectors seems beneficial in repairing or replacing impaired genes in human. Therapeutic applications
- 14. 3. Liposomes A liposomebeing composed of a lipid bilayer can be used in gene therapy due to its ability to pass through lipid bilayers and cell membranes of the target. Recent use of several groups of liposomes in a local delivery has been found to be convincingly effective. Liposomes can also help achieve targeted therapy. Zhang et al demonstrated widespread reporter expression in the brains of rhesus monkeys by linking nanoparticle (such as polyethylene glycol) treated liposomes to a monoclonal antibody for human insulin reporter. These successful trials reflect the future of targeted therapy and the importance of nanometer-sized constructs for the advancement of molecular medicine. Therapeutic applications
- 15. 4. Surfaces In nature,there are a multitude of examples of the complicated interactions between molecules and surfaces. For example, the interactions between blood cells and the brain or between fungal pathogens and infection sites rely on complex interplays between cells and surface characteristics. Nanofabrication unravels the complexity of these interactions by modifying surface characteristics with nanoscale resolutions, which can lead to hybrid biological systems. This hybrid material can be used to screen drugs, as sensors, or as medical devices and implants. Nanosystems, owned by the Irish drug company Elan, developed a polymer coating capable of changing the surface of drugs that have poor water solubility. Therapeutic applications
- 16. 5. Biomolecular Engineering Theexpense and time involved in traditional biomolecule designing limit the availability of bioactive molecules. Nanoscale assembly and synthesis techniques provide an alternative to traditional methods. Improvements can be achieved due to the ability to carry out chemical and biological reactions on solid substrates, rather than through the traditional solution based processes. The use of solid substrate usually means less waste and the ability to manipulate the biomolecule far more precisely. EngeneOS (Waltham, Massachusetts) pioneered the field of biomolecular engineering. The company developed the engineered genomic operating systems that create programmable biomolecular machines employing natural and artificial building blocks. These biomolecule machines have broad range of commercial applications-as biosensors, in chemical synthesis and processing, as bioelectronic devices and materials, in nanotechnology, in functional genomics and in drug discovery. Therapeutic applications
- 17. 6. Biopharmaceuticals Nanobiotechnology candevelop drugs for diseases that conventional pharmaceuticals cannot target. The pharmaceutical industry traditionally focuses on developing drugs to treat a defined universe of about five hundred confirmed disease targets. But approximately 70 to 80 percent of the new candidates for drug development fail, and these failures are often discovered late in the development process, with the loss of millions of dollars in R&D investments. Nanoscale techniques for drug development will be a boon to small companies, which cannot employ hundreds of organic chemists to synthesize and test thousands of compounds. Nanobiotechnology brings the ability to physically manipulate targets, molecules and atoms on solid substrates by tethering them to biomembranes and controlling where and when chemical reactions take place, in a fast process that requires few materials (reagents and solutions). This advance will reduce drug discovery costs, will provide a large diversity of compounds, and will facilitate the development of highly specific drugs. Potentia Pharmaceuticals (Louisville, Kentucky) is an early-stage company that is attempting to streamline the drug development process with the use of nanotechnologies. Therapeutic applications
- 18. 7. Nanotechnology incardiac therapy Nanotechnology is currently offering promising tools for applications in modern cardiovascular science to explore existing frontiers at the cellular level and treat challenging cardiovascular diseases more effectively. These tools can be applied in diagnosis, imaging and tissue engineering. Miniaturized nanoscale sensors like quantum dots (QDs), nanocrystals, and nanobarcodes are capable of sensing and monitoring complex immune signals in response to cardiac or inflammatory events. Nanotechnology can also help detect and describe clinically-significant specific mechanisms implicated in cardiac disorders. In addition, it is useful in designing atomic-scale machines that can be incorporated into biological systems at the molecular level. Introduction of these newly designed nanomachines may positively change many ideas and hypotheses in the treatment of critical cardiovascular diseases. Nanotechnology could also have great impact in tackling issues like unstable plaques and clarification of valves. Thus, this approach could be a real milestone of success in achieving localized and sustained arterial and cardiac drug therapy for the management of cardiovascular diseases. Therapeutic applications
- 19. 8. Nanotechnology indental care Nanotechnology will have future medical applications in the field of dentistry. The role of nanodentistry by means of the use of nanomaterials, biotechnology, and nanorobotics will ensure better oral health. Millions of people currently receiving poor dental care will benefit from such remarkable breakthrough in the science of dental health. Moreover, nanodental techniques in major tooth repair may also evolve. Reconstructive dental nanorobots could be used in selective and precise occlusion of specific tubules within minutes, and this will facilitate quick and permanent recovery. The advantage of nanodentistry in natural tooth maintenance could also be significant. Covalently-bonded artificial materials like sapphire may replace upper enamel layer to boost the appearance and durability of teeth. Therapeutic applications
- 20. 9. Nanotechnology inorthopedic applications Nanomaterials sized between 1 and 100 nm have role to play as new and functional constituents of bones being also made up of nanosized organic and mineral phases. Nanomaterials, nanopolymers, carbon nanofibers, nanotubes, and ceramic nanocomposites may help with more efficient deposition of calcium-containing minerals on implants. Based on these evidences and observations, nanostructure materials represent a unique realm of research and development that may improve the attachment of an implant to the surrounding bone matters by enhancing bone cell interactions, and this will indeed aid in improving orthopedic implant efficacy while drastically minimizing patient-compliance problems. Therapeutic applications
- 21.
- 22. There is muchdebate on the future implications of nanobiotechnology. It could create and suggest implementation of a choice of various new materials and devices potentially useful in the field of medicine, electronics, biomaterials and energy production. Nevertheless, this approach raises many of the same issues as any new technology, including problems with toxicity and environmental impact of nanomaterials and their potential effects on global economics, as well as speculation about various doomsday scenarios. These concerns have accounted for a debate among advocacy groups and governments on whether special statutory regulation of nanobiotechnology is warranted.
- 23. Despite the existenceof some disputes, this technology renders immense hope for the future. It may lead to innovations by playing a prominent role in various biomedical applications ranging from drug delivery and gene therapy to molecular imaging, biomarkers and biosensors. One of these applications being the prime research objective of the present time would be target- specific drug therapy and methods for early diagnosis and treatment of diseases. Two types of medical applications are already emerging, both in clinical diagnosis and in R&D. Imaging applications, such as quantum dot technology are already being licensed and applications for monitoring cellular activities in tissue are coming soon. The second major type of application involves the development of highly specific and sensitive means of detecting nucleic acids and proteins. By 2015 to 2020, we will see that products being tested in academic and government laboratories will be creeping into commercialization. Sparse cell isolation and molecular filtration applications should, by then, make it to market. Some of the drug delivery systems should be commercialized or in advanced clinical trials. For example - drug delivery systems have been developed by NanoSystems or by American Pharmaceutical Partners, which is testing the encapsulation of Taxol, a cancer drug in a nanopolymer called paclitaxel. Most medical devices and therapeutics are a decade or more away from market. Therefore, drug target manipulation as well as device implantation requires a complex technical infrastructure like nanotechnology as well as complex regulatory management.
- 24. Continuous advancements innanomedicine have opened up its opportunities for application in a variety of medical disciplines. Its future application as diagnostic and regenerative medicine is currently being investigated. In diagnosis, detection of diseased cells would be faster, possibly at the point of a single sick cell, while allowing diseased cells to be cured at once before they spread into and affect other parts of the body. Also, individuals suffering from major traumatic injuries or impaired organ functions could benefit from the use of nanomedicine.
- 25.